25 companies

Genomed Spólka Akcyjna

Market Cap: zł40.7m

Provides DNA and RNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł31.00

7D

8.4%

1Y

20.2%

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.

CLN

zł20.40

7D

-1.7%

1Y

-10.3%

Biogened

Market Cap: zł46.4m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł19.60

7D

2.6%

1Y

-26.9%

Selvita

Market Cap: zł520.4m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł27.95

7D

-1.9%

1Y

-15.6%

Captor Therapeutics Spolka Akcyjna

Market Cap: zł451.1m

A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.

CTX

zł70.70

7D

-3.8%

1Y

75.4%

Bioceltix

Market Cap: zł437.6m

Engages in the development of veterinary biologics based on mesenchymal stem cells.

BCX

zł80.40

7D

-3.6%

1Y

-23.3%

NanoGroup

Market Cap: zł106.1m

Operates as a biotechnology company in Poland.

NNG

zł2.49

7D

1.6%

1Y

-5.9%

genXone

Market Cap: zł18.2m

Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.

GX1

zł5.50

7D

-4.5%

1Y

0%

Poltreg

Market Cap: zł155.0m

A biotechnology company, researches and develops therapies for autoimmune diseases in Poland.

PTG

zł25.90

7D

-3.7%

1Y

-13.7%

Green Zebras Spolka Akcyjna

Market Cap: zł15.9m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

GRZ

zł9.90

7D

-4.8%

1Y

18.6%

Ryvu Therapeutics

Market Cap: zł381.9m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł18.22

7D

4.5%

1Y

-39.3%

Molecure

Market Cap: zł126.7m

A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.

MOC

zł6.17

7D

0.3%

1Y

-22.1%

Labocanna

Market Cap: zł4.6m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.22

7D

2.9%

1Y

-29.4%

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

HEN

zł2.32

7D

0%

1Y

-34.6%

BIOTON

Market Cap: zł326.7m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

BIO

zł3.80

7D

-2.7%

1Y

-8.7%

Stem Cells Spin

Market Cap: zł19.8m

Operates as a biotechnology company in Poland.

SCS

zł0.49

7D

10.5%

1Y

35.0%

Urteste

Market Cap: zł68.4m

Engages in the research and development of diagnostic tests for cancers in Poland.

URT

zł45.30

7D

3.9%

1Y

-13.2%

Genomtec

Market Cap: zł57.2m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

GMT

zł3.78

7D

-4.3%

1Y

-39.0%

Read-Gene

Market Cap: zł58.8m

Engages in the detection, prevention, and treatment of various types of cancer.

RDG

zł4.99

7D

0.2%

1Y

-7.2%

Cannabis Poland

Market Cap: zł12.8m

Operates in the medical cannabis industry in Poland.

CBD

zł0.17

7D

-1.7%

1Y

-44.9%

Tecnovatica

Market Cap: zł6.2m

Does not have significant operations.

TEC

zł0.60

7D

20.0%

1Y

60.4%

Medicofarma Biotech

Market Cap: zł26.8m

Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.

MDB

zł0.39

7D

0.5%

1Y

26.6%

MultiQure

Market Cap: zł38.7m

A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

MQR

zł3.06

7D

-4.1%

1Y

-54.7%

Mabion

Market Cap: zł121.9m

A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.

MAB

zł7.52

7D

0%

1Y

-21.4%

Synthaverse

Market Cap: zł220.9m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas in Poland, the rest of the European Union, and internationally.

SVE

zł2.92

7D

-0.8%

1Y

-40.5%